- Home
- LEE vs BRNS Comparison
LEE vs BRNS Comparison
Compare LEE & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- BRNS
- Stock Information
- Founded
- LEE 1890
- BRNS 2016
- Country
- LEE United States
- BRNS United Kingdom
- Employees
- LEE N/A
- BRNS N/A
- Industry
- LEE Newspapers/Magazines
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- BRNS Health Care
- Exchange
- LEE Nasdaq
- BRNS Nasdaq
- Market Cap
- LEE 38.2M
- BRNS 40.0M
- IPO Year
- LEE N/A
- BRNS 2021
- Fundamental
- Price
- LEE $6.38
- BRNS $0.90
- Analyst Decision
- LEE
- BRNS Strong Buy
- Analyst Count
- LEE 0
- BRNS 1
- Target Price
- LEE N/A
- BRNS $3.00
- AVG Volume (30 Days)
- LEE 35.1K
- BRNS 10.9K
- Earning Date
- LEE 07-31-2025
- BRNS 08-07-2025
- Dividend Yield
- LEE N/A
- BRNS N/A
- EPS Growth
- LEE N/A
- BRNS N/A
- EPS
- LEE N/A
- BRNS N/A
- Revenue
- LEE $591,094,000.00
- BRNS $14,969,000.00
- Revenue This Year
- LEE N/A
- BRNS N/A
- Revenue Next Year
- LEE N/A
- BRNS N/A
- P/E Ratio
- LEE N/A
- BRNS N/A
- Revenue Growth
- LEE N/A
- BRNS 4381.74
- 52 Week Low
- LEE $5.83
- BRNS $0.64
- 52 Week High
- LEE $19.63
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- LEE 43.72
- BRNS 48.03
- Support Level
- LEE $6.28
- BRNS $0.83
- Resistance Level
- LEE $7.00
- BRNS $0.94
- Average True Range (ATR)
- LEE 0.36
- BRNS 0.05
- MACD
- LEE 0.06
- BRNS -0.00
- Stochastic Oscillator
- LEE 48.72
- BRNS 34.88
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.